KUMAR AMIT

High conviction

Director, Chief Executive Officer · Anixa Biosciences Inc

Every open-market stock purchase KUMAR AMIT has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$71.6K
Open-market buys
5
Companies
1
Last buy
Jul 27, 2026

Where the buys stand today

Cluster participation

Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Jul 27, 2026
ANIXcluster
5,000$3.44$17.2KSEC ↗
Jul 27, 2026
ANIXcluster
3,188$3.37$10.7KSEC ↗
Jul 24, 2026
ANIXcluster
3,000$3.73$11.2KSEC ↗
Jul 20, 2026
ANIXcluster
5,000$3.46$17.3KSEC ↗
Jul 10, 2026
ANIXcluster
5,000$3.04$15.2KSEC ↗

Get alerted the next time KUMAR AMIT — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from KUMAR AMIT's Form 4 filings on SEC EDGAR (CIK 1191905) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.